Dopamine Uptake Inhibitors
"Dopamine Uptake Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that block the transport of DOPAMINE into axon terminals or into storage vesicles within terminals. Most of the ADRENERGIC UPTAKE INHIBITORS also inhibit dopamine uptake.
| Descriptor ID |
D018765
|
| MeSH Number(s) |
D27.505.519.562.437.220 D27.505.519.625.150.800 D27.505.519.625.600.220 D27.505.696.577.150.800 D27.505.696.577.600.220
|
| Concept/Terms |
Dopamine Uptake Inhibitors- Dopamine Uptake Inhibitors
- Reuptake Inhibitors, Dopamine
- Inhibitors, Dopamine Uptake
- Uptake Inhibitors, Dopamine
- Inhibitors, Dopamine Reuptake
- Dopamine Reuptake Inhibitors
|
Below are MeSH descriptors whose meaning is more general than "Dopamine Uptake Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Dopamine Uptake Inhibitors".
This graph shows the total number of publications written about "Dopamine Uptake Inhibitors" by people in this website by year, and whether "Dopamine Uptake Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dopamine Uptake Inhibitors" by people in Profiles.
-
Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program. JAMA Intern Med. 2013 May 13; 173(9):817-9.
-
Dopamine genes and nicotine dependence in treatment-seeking and community smokers. Neuropsychopharmacology. 2009 Sep; 34(10):2252-64.
-
Extended cognitive behavior therapy for cigarette smoking cessation. Addiction. 2008 Aug; 103(8):1381-90.
-
Abstinence rates achieved with buproprion corrected. Oncology (Williston Park). 1998 Sep; 12(9):1303.